126 related articles for article (PubMed ID: 15297165)
1. Quantitative histopathology and chromosome 9 polysomy in a clinical trial of 4-HPR.
Yamal JM; Cox D; Hittelman WN; Boiko I; Malpica A; Guillaud M; MacAulay C; Follen M; Vlastos AT
Gynecol Oncol; 2004 Aug; 94(2):296-306. PubMed ID: 15297165
[TBL] [Abstract][Full Text] [Related]
2. Cervical chromosome 9 polysomy: validation and use as a surrogate endpoint biomarker in a 4-HPR chemoprevention trial.
Kim HG; Yamal JM; Xu XC; Hu W; Boiko I; Linares A; Vlastos AT; Atkinson EN; Malpica A; Hittelman WN; Follen M
Gynecol Oncol; 2005 Dec; 99(3 Suppl 1):S32-7. PubMed ID: 16154183
[TBL] [Abstract][Full Text] [Related]
3. A randomized clinical trial of 4-hydroxyphenylretinamide for high-grade squamous intraepithelial lesions of the cervix.
Follen M; Atkinson EN; Schottenfeld D; Malpica A; West L; Lippman S; Zou C; Hittelman WN; Lotan R; Hong WK
Clin Cancer Res; 2001 Nov; 7(11):3356-65. PubMed ID: 11705848
[TBL] [Abstract][Full Text] [Related]
4. DNA image cytometric measurement as a surrogate end point biomarker in a phase I trial of alpha-difluoromethylornithine for cervical intraepithelial neoplasia.
Boiko IV; Mitchell MF; Pandey DK; White RA; Hu W; Malpica A; Nishioka K; Boone CW; Atkinson EN; Hittelman WN
Cancer Epidemiol Biomarkers Prev; 1997 Oct; 6(10):849-55. PubMed ID: 9332769
[TBL] [Abstract][Full Text] [Related]
5. Epidermal growth factor receptor expression in cervical intraepithelial neoplasia and its modulation during an alpha-difluoromethylornithine chemoprevention trial.
Boiko IV; Mitchell MF; Hu W; Pandey DK; Mathevet P; Malpica A; Hittelman WN
Clin Cancer Res; 1998 Jun; 4(6):1383-91. PubMed ID: 9626454
[TBL] [Abstract][Full Text] [Related]
6. Study of numerical aberrations of chromosome 1 by fluorescent in situ hybridization and DNA content by densitometric analysis on (pre)-malignant cervical lesions.
Segers P; Haesen S; Castelain P; Amy JJ; De Sutter P; Van Dam P; Kirsch-Volders M
Histochem J; 1995 Jan; 27(1):24-34. PubMed ID: 7713754
[TBL] [Abstract][Full Text] [Related]
7. Cervical cytology by means of fluorescence in situ hybridization with a set of chromosome-specific DNA probes.
Hariu H; Matsuta M
J Obstet Gynaecol Res; 1996 Apr; 22(2):163-70. PubMed ID: 8697347
[TBL] [Abstract][Full Text] [Related]
8. N-(4-hydroxyphenyl)retinamide in the chemoprevention of squamous metaplasia and dysplasia of the bronchial epithelium.
Kurie JM; Lee JS; Khuri FR; Mao L; Morice RC; Lee JJ; Walsh GL; Broxson A; Lippman SM; Ro JY; Kemp BL; Liu D; Fritsche HA; Xu X; Lotan R; Hong WK
Clin Cancer Res; 2000 Aug; 6(8):2973-9. PubMed ID: 10955773
[TBL] [Abstract][Full Text] [Related]
9. Nuclear morphometry as an intermediate endpoint biomarker in chemoprevention of cervical carcinoma using alpha-difluoromethylornithine.
Poulin N; Boiko I; MacAulay C; Boone C; Nishioka K; Hittelman W; Mitchell MF
Cytometry; 1999 Oct; 38(5):214-23. PubMed ID: 10516607
[TBL] [Abstract][Full Text] [Related]
10. Pilot trial of the safety, tolerability, and retinoid levels of N-(4-hydroxyphenyl) retinamide in combination with tamoxifen in patients at high risk for developing invasive breast cancer.
Conley B; O'Shaughnessy J; Prindiville S; Lawrence J; Chow C; Jones E; Merino MJ; Kaiser-Kupfer MI; Caruso RC; Podgor M; Goldspiel B; Venzon D; Danforth D; Wu S; Noone M; Goldstein J; Cowan KH; Zujewski J
J Clin Oncol; 2000 Jan; 18(2):275-83. PubMed ID: 10637240
[TBL] [Abstract][Full Text] [Related]
11. Interphase cytogenetic analysis of cervical intraepithelial neoplasia.
Bulten J; Poddighe PJ; Robben JC; Gemmink JH; de Wilde PC; Hanselaar AG
Am J Pathol; 1998 Feb; 152(2):495-503. PubMed ID: 9466576
[TBL] [Abstract][Full Text] [Related]
12. Human telomerase RNA gene (TERC) gain and polysomy of chromosome 3 in cervicovaginal liquid-based pap preparations: a fluorescence in situ hybridization study.
Sui W; Ou M; Chen J; Yu J; Zhang Y; Lan H; Huang H; Dai Y
Eur J Gynaecol Oncol; 2010; 31(4):375-9. PubMed ID: 20882876
[TBL] [Abstract][Full Text] [Related]
13. Correspondence re: M. Follen et al., a randomized clinical trial of 4-hydroxyphenylretinamide for high-grade squamous intraepithelial lesions of the cervix.
Formelli F
Clin Cancer Res; 2002 May; 8(5):1310-2; author reply 1313. PubMed ID: 12006553
[No Abstract] [Full Text] [Related]
14. Enhancement of regression of cervical intraepithelial neoplasia II (moderate dysplasia) with topically applied all-trans-retinoic acid: a randomized trial.
Meyskens FL; Surwit E; Moon TE; Childers JM; Davis JR; Dorr RT; Johnson CS; Alberts DS
J Natl Cancer Inst; 1994 Apr; 86(7):539-43. PubMed ID: 8133537
[TBL] [Abstract][Full Text] [Related]
15. Retinoids for preventing the progression of cervical intra-epithelial neoplasia.
Helm CW; Lorenz DJ; Meyer NJ; Rising WR; Wulff JL
Cochrane Database Syst Rev; 2007 Oct; (4):CD003296. PubMed ID: 17943787
[TBL] [Abstract][Full Text] [Related]
16. A phase I-II preoperative biomarker trial of fenretinide in ascitic ovarian cancer.
Colombo N; Formelli F; Cantù MG; Parma G; Gasco M; Argusti A; Santinelli A; Montironi R; Cavadini E; Baglietto L; Guerrieri-Gonzaga A; Viale G; Decensi A
Cancer Epidemiol Biomarkers Prev; 2006 Oct; 15(10):1914-9. PubMed ID: 17035399
[TBL] [Abstract][Full Text] [Related]
17. Transition of high-grade cervical intraepithelial neoplasia to micro-invasive carcinoma is characterized by integration of HPV 16/18 and numerical chromosome abnormalities.
Hopman AH; Smedts F; Dignef W; Ummelen M; Sonke G; Mravunac M; Vooijs GP; Speel EJ; Ramaekers FC
J Pathol; 2004 Jan; 202(1):23-33. PubMed ID: 14694518
[TBL] [Abstract][Full Text] [Related]
18. DNA quantification in cervical intraepithelial neoplasia thick tissue sections by confocal laser scanning microscopy.
Crist KA; Kim K; Goldblatt PJ; Boone CW; Kelloff GJ; You M
J Cell Biochem Suppl; 1996; 25():49-56. PubMed ID: 9027598
[TBL] [Abstract][Full Text] [Related]
19. TOPical Imiquimod treatment of high-grade Cervical intraepithelial neoplasia (TOPIC trial): study protocol for a randomized controlled trial.
Koeneman MM; Kruse AJ; Kooreman LFS; Zur Hausen A; Hopman AHN; Sep SJS; Van Gorp T; Slangen BFM; van Beekhuizen HJ; van de Sande M; Gerestein CG; Nijman HW; Kruitwagen RFPM
BMC Cancer; 2016 Feb; 16():132. PubMed ID: 26897518
[TBL] [Abstract][Full Text] [Related]
20. Association between the stages of cervical cancer and chromosome 1 aneusomy.
Cortés-Gutiérrez EI; Dávila-Rodríguez MI; Muraira-Rodríguez M; Said-Fernández S; Cerda-Flores RM
Cancer Genet Cytogenet; 2005 May; 159(1):44-7. PubMed ID: 15860356
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
